Biologics: Market Opportunities for Chemical Suppliers

Base Year: 2020
Published: Q3 2021
Forecasts to 2025
Download Brochure

Base Year: 2023
To be Published: Q1 2024
Forecasts to 2028
Download Brochure

The influx of biologics in the drug development pipeline is creating new opportunities for various chemical products along the entire value chain. The opportunities lie for not only chemicals used as key components of finished biologic drug dosage but also the ingredients that play an important role in the development and manufacturing of the drug itself. With this study, Kline provides a comprehensive assessment of opportunities created by biologics for chemicals suppliers.

Scope

• A comprehensive analysis of global biopharmaceuticals industry developments and their impact on demand for specialty chemicals in different stages of production, including:
  • — Upstream manufacturing
    • — Classic cell culture media, cell expression systems, cell culture ingredients and supplements, and buffers
  • — Downstream processing
    • — Stabilizers, surfactants, salts, antioxidants, and buffers
  • — Final formulation
    • — Stabilizers and bulking agents, surfactants, salts, antioxidants, buffers, vaccine adjuvants, and chelating agents

Table of Contents

Introduction to the Biopharmaceutical Industry

• Overview of biologic pharmaceuticals
• Types of biologic pharmaceuticals
• Major biopharmaceutical companies
• Commercial examples of biologic formulations

Bioprocessing Techniques

• Overview
• Trends and outlook

Recent Developments in the Biopharmaceutical Industry

• Pandemic-caused dynamics
• Developments in the drug pipeline
• Ingredient consumption patterns
• Existing and future drug options

Ingredients for Bioprocessing

• Market size
• Grades and prices
• Supplier landscape
• Potential growth scenarios
• Biologics ingredients and excipients forecast

Report Benefits

This report helps chemical suppliers understand the entire biologics value chain and identify business opportunities within a key growth area. It also serves as an invaluable tool in the strategic planning process. In addition, the report allows subscribers to:

• Develop business strategies by understanding the trends that are driving the consumption of chemicals related to biopharmaceutical processing and formulation globally
• Identify key market participants at various levels of the value chain
• Develop market-entry and market-expansion strategies and identify specific chemicals or categories poised for strong growth